the Comparison of Voice Quality in Early Laryngeal Cancer Between Surgery and Radiotherapy - Full Text View

the Comparison of Voice Quality in Early Laryngeal Cancer Between Surgery and Radiotherapy

This study is currently recruiting participants.
Verified by Tehran University of Medical Sciences, May 2007

Sponsored by:	Tehran University of Medical Sciences
Information provided by:	Tehran University of Medical Sciences
ClinicalTrials.gov Identifier:	NCT00497588

Purpose

early laryngeal cancer is a well known field with great controversy in treatment. two options are available in treatment of patients the first one is partial laryngectomy and the second one is radiotherapy.one of major concern of patients have been the quality of voice ,so we design this trial to answer the priority of each options.

Condition	Intervention	Phase
Voice Quality	Procedure: surgery ,radiotherapy	Phase IV

MedlinePlus related topics:

Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Further study details as provided by Tehran University of Medical Sciences:

Primary Outcome Measures:

quality of voice [ Time Frame: 3 to 6 month after therapy ]

Secondary Outcome Measures:

quality of life [ Time Frame: 6 month later ]

Estimated Enrollment:	33
Study Start Date:	March 2007
Estimated Study Completion Date:	December 2009

Detailed Description:

early laryngeal cancer is a well known field with great controversy in treatment. two options are available in treatment of patients the first one is partial laryngectomy and the second one is radiotherapy.one of major concern of patients have been the quality of voice as part of quality of life ,so we design this clinical randomised trial to answer the priority of each options.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Early laryngeal cancer

Exclusion Criteria:

No history of radiotherapy and collagen vascular disease

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00497588

Contacts


Contact: babak saedi, professor	98219123872469	saedi@tums.ac.ir

Contact: mohamad sadeghi, professor	98219121153594	sadeghi@tums.ac.ir

Locations


Iran, Islamic Republic of
	Imam Khomainee hospital	Recruiting
	Tehran, Iran, Islamic Republic of, 19799
	Contact: babak saedi, professor 98219123872469 saedi@tums.ac.ir
	Contact: Mohamad sadeghi, professor 98219121153594 sadeghi@tums.ac.ir
	Sub-Investigator: Mohamad sadeghi, professor

Sponsors and Collaborators

Tehran University of Medical Sciences

Investigators


Principal Investigator:	babak saedi, professor	tehran university of medical science

More Information

Study ID Numbers:	bs-86-01-48-5497
First Received:	July 4, 2007
Last Updated:	July 5, 2007
ClinicalTrials.gov Identifier:	NCT00497588
Health Authority:	Iran: TUMS ethics committee